Adient (ADNT) Cash & Equivalents (2015 - 2026)

Adient (ADNT) has reported Cash & Equivalents for 12 consecutive years, with $831.0 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $831.0 million, up 10.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $831.0 million (up 10.21% YoY), and the FY2025 annual result was $958.0 million, up 1.38% from the prior year.
• Cash & Equivalents was $831.0 million for Q1 2026 at Adient, down from $855.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $1.1 billion in Q1 2022 and troughed at $754.0 million in Q1 2025.
• Average Cash & Equivalents over 5 years is $914.7 million, with a median of $901.0 million recorded in 2022.
• Year-over-year, Cash & Equivalents plunged 56.68% in 2022 and grew 17.21% in 2023.
• Over 5 years, Cash & Equivalents stood at $901.0 million in 2022, then advanced by 9.88% to $990.0 million in 2023, then slipped by 13.13% to $860.0 million in 2024, then declined by 0.58% to $855.0 million in 2025, then dropped by 2.81% to $831.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $831.0 million in Q1 2026, $855.0 million in Q4 2025, and $958.0 million in Q3 2025.